GlassScriptPhysician profile
Madhumitha Reddy
NPI 1568724417
$13,418.21
in general payments reported to CMS, 2019-2025
54 companies · $2,354 in 2025
The $2,354 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,028 · 2020: $2,829 · 2021: $1,774 · 2022: $1,557 · 2023: $1,437 · 2024: $2,440 · 2025: $2,354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,634 · Travel and Lodging: $337 · Education: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,634.11 |
| Travel and Lodging | $336.61 |
| Education | $260.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $2,804.25 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $1,053.42 | 2019-2025 | Erleada, Akeega, Balversa |
| Teleflex LLC | $936.24 | 2021-2025 | Urolift |
| Cipla USA INC. | $762.98 | 2020 | |
| Pfizer INC. | $735.28 | 2019-2025 | |
| Coloplast Corp | $649.44 | 2019-2025 | Speedicath |
| Myovant Sciences INC. | $564.45 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $559.37 | 2022-2025 | Trelstar, Tlando |
| Urogen Pharma, INC. | $522.97 | 2022-2025 | Jelmyto |
| Intuitive Surgical, INC. | $454.76 | 2019-2024 | Da Vinci Surgical System |
| Astellas Pharma US INC | $405.82 | 2019-2025 | Xtandi |
| Antares Pharma, INC. | $389.43 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Bayer Healthcare Pharmaceuticals INC. | $349.77 | 2019-2025 | |
| Abbvie INC. | $311.03 | 2023-2025 | |
| Immunitybio, INC. | $224.88 | 2024-2025 |
Show all 53 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madhumitha Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.